Skip to main content
METabolic EXplorer logo

METabolic EXplorer — Investor Relations & Filings

Ticker · METEX ISIN · FR0004177046 LEI · 969500VI1GSBPGD9B460 PA Manufacturing
Open in API
Filings indexed 524 across all filing types
Latest filing 2011-09-12 Board/Management Inform…
Country FR France
Listing PA METEX

About METabolic EXplorer

https://www.metabolic-explorer.com/

METabolic EXplorer (METEX) is an industrial biotechnology company specializing in the development and industrialization of fermentation bioprocesses. The company produces functional ingredients and chemical intermediates from renewable, non-food raw materials, offering sustainable alternatives to petrochemical processes. Its portfolio is centered on three main product families: 1,3-propanediol (PDO) for cosmetics, liquid polymers, and textiles; butyric acid (BA) for animal nutrition and the flavors and fragrances market; and amino acids for animal feed. The company operates through its subsidiaries, METEX NØØVISTA, which manages the PDO and BA production, and METEX NØØVISTAGO, which focuses on amino acids and ingredients for animal nutrition.

Recent filings

Filing Released Lang Actions
Arrivée de Christophe Lacroix au poste de Directeur, en charge des alliances, des partenariats et du Business Management
Board/Management Information Classification · 98% confidence The document is a press release from METabolic EXplorer announcing the arrival of Christophe Lacroix to the Management Committee in a senior role ('Directeur, en charge des alliances, des partenariats et du Business Management'). This directly corresponds to the definition of 'Board/Management Information' (MANG), which covers announcements of changes in senior management. The document is short and appears to be a direct announcement rather than a comprehensive report (like 10-K or IR).
2011-09-12 French
Information relative au nombre total de droits de vote et d'actions composant le capital
Declaration of Voting Results & Voting Rights Announcements Classification · 98% confidence The document is titled "METabolic EXplorer : information relative au nombre total de droits de vote et d'actions composant le capital" (Information relative to the total number of voting rights and shares comprising the capital). It explicitly references Article 223-16 of the AMF General Regulation and provides a breakdown of total shares, theoretical voting rights, and exercisable voting rights as of a specific date (31/07/2011). This content directly relates to the official declaration of voting rights and share capital structure, which aligns perfectly with the definition of 'Declaration of Voting Results & Voting Rights Announcements' (DVA). The document is short and appears to be a formal regulatory disclosure, not a comprehensive report or a mere announcement of a report.
2011-08-05 French
Information relative au nombre total de droits de vote et d'actions composant le capital
Declaration of Voting Results & Voting Rights Announcements Classification · 98% confidence The document is titled "METabolic EXplorer : information relative au nombre total de droits de vote et d'actions composant le capital" and is dated July 18, 2011, with a reference date of 30/06/2011. It explicitly references Article 223-16 of the AMF (Autorité des Marchés Financiers) general regulation and provides a breakdown of total voting rights and shares, including theoretical voting rights and shares deprived of voting rights (self-held shares). This content directly relates to the official declaration of voting results and capital structure disclosure required by regulators, which aligns best with the 'Declaration of Voting Results & Voting Rights Announcements' category.
2011-07-18 French
Turnover for first-half 2011
Earnings Release Classification · 99% confidence The document is titled "METabolic EXplorer: turnover for first-half 2011" and is dated July 13, 2011. It explicitly reports financial figures (turnover, cash position) and operational updates (IP portfolio) for the first half of 2011 (a period shorter than a year). This content structure aligns perfectly with a comprehensive financial report for an interim period, which corresponds to the Interim / Quarterly Report category (IR). It is not just a brief announcement of results (ER), nor is it the full annual report (10-K). H1 2011
2011-07-13 English
Chiffre d'affaires du 1er semestre 2011
Earnings Release Classification · 99% confidence The document is titled "METabolic EXplorer : chiffre d'affaires du 1 er semestre 2011" (Revenue for the 1st half of 2011) and explicitly announces the revenue figures for the first six months of the year (ending June 30, 2011). This content structure—a brief announcement focusing on key financial metrics for a specific interim period (six months)—aligns perfectly with the definition of an Interim / Quarterly Report (IR). Although it is a short announcement, it contains the core financial results for the period, unlike an RPA which typically just announces the *publication* of a report. Since it details the H1 results, it is classified as IR. H1 2011
2011-07-13 French
Bilan semestriel du contrat de liquidité
Regulatory Filings Classification · 99% confidence The document is titled "METabolic EXplorer : Bilan semestriel du contrat de liquidité" (METabolic EXplorer: Semi-annual statement of the liquidity contract). It explicitly reports the status of a liquidity contract (share holdings and cash balance) as of June 30, 2011, comparing it to the previous semi-annual balance (December 31, 2010). This is a specific financial update related to market operations, but it is not a full financial report (10-K or IR), an earnings release (ER), or a dividend announcement (DIV). It details the status of shares held under a specific agreement, which falls under general financial/market activity reporting. Given the options, this type of specific, periodic financial disclosure that isn't a comprehensive report or a standard regulatory filing like insider trading (DIRS) or major shareholding (MRQ) is best categorized as a general Regulatory Filing (RNS) or potentially a Capital/Financing Update (CAP) if the liquidity contract is viewed as a financing tool. However, since it is a routine, periodic report on a specific market mechanism (liquidity contract), and not a major capital change or a standard earnings report, RNS serves as the most appropriate general regulatory disclosure category for non-standard periodic financial updates, or it could be considered a specialized financial notice. Given the context of reporting on share holdings/cash related to a market stabilization contract, it is a specific regulatory disclosure. I will classify it as RNS as it is a specific, non-standard periodic financial disclosure.
2011-07-08 French

Browse filings by year

17 years

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.